• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

7 New Approved Drugs for Primary Care: Q2 2023

News
Slideshow

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about?

Another quarter has come and gone, which means Patient Care Online has compiled another list of new drugs approved by the US Food and Drug Administration (FDA) for conditions that are often seen in primary care. Scroll through the slides below to find details on the first oral antiviral pill approved by the FDA for the treatment of COVID-19 in adults, a novel formulation of rizatriptan benzoate for acute migraine treatment, the first vaccine against respiratory syncytial virus, and 4 more.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Shingrix Effective Against Shingles for up to 11 Years Post-Vaccination: Daily Dose / image credit: ©New Africa/AdobeStock

Shingrix Effective Against Shingles for up to 11 Years Post-Vaccination: Daily Dose

April 25th 2024
Article

Your daily dose of the clinical news you may have missed.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women / Image credit: ©harunyigit/AdobeStock

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

April 24th 2024
Article

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought / Image credit: ©Horacio Selva/AdobeStock

New Data Suggest Atrial Fibrillation May be More Common in Younger Adults than Previously Thought

April 23rd 2024
Article

Patients with AF aged younger than 65 years have substantial comorbidity burden that may impact their future risk of mortality, reported researchers.

Maternal Vascular Indices, Biomarkers at 36 Week's Gestation Predict Preeclampsia, New Study Concludes / image credit hypertension in pregnancy ©Capifrutta/shutterstock.com

Maternal Vascular Indices, Biomarkers at 36 Week's Gestation Predict Preeclampsia, New Study Concludes

April 23rd 2024
Article

Increased arterial stiffness and elevated central BP are among factors researchers found to have strong discriminatory value for PE at term and postpartum.

© 2024 MJH Life Sciences

All rights reserved.